IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Preclinical biotech developing allogenic stem cell treatments for multiple cancers.
Industry: Health Care
Latest Trade: $3.13 0.00 (0.0%)
First Day Return: +14.2%
Return from IPO: -84.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/28/2021 |
Offer Price | $20.00 |
Price Range $18.00 - $20.00 | |
Offer Shares (mm) | 10.6 |
Deal Size ($mm) | $211 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/17/2021 |
Offer Price | $20.00 |
Price Range $18.00 - $20.00 | |
Offer Shares (mm) | 10.6 |
Deal Size ($mm) | $211 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
BofA Securities |
more |
Company Data | |
---|---|
Headquarters | Philadelphia, PA, United States |
Founded | 2018 |
Employees | 97 |
Website www.centurytx.com |